Initial Therapeutics is a startup. Brouky records 1 investor associated with the company.
Initial Therapeutics is a biotechnology company launched with financing from Apple Tree Partners to develop a new class of drugs designed to prevent the formation of difficult-to-drug protein targets.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.